Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Use server logs, user agent strings, and IP verification to manage GPT, Claude, Gemini, and more while protecting bandwidth ...

Vibe coding is the practice of using natural language to ask AI to build you something, such as a web app, landing page, or ...

Miami-based founders Justin Elliott and Jahreem Samuels have scored an investment for their AI and blockchain-verified ...

Caralynn Nowinski Collens, Ramille Shah, and Adam Jakus spent years developing an innovative technology to regenerate injured bone. The results, they thought, were . . . okay. The company they founded ...

Small Cap Annovis Bio Inc. (NYSE: ANVS) stock is trading higher on Monday, with a session volume of 12.29 million compared to the average volume of 615.12 thousand as per data from Benzinga Pro. A ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...

Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. How does a venerable American brand known for creating the ...

LatchBio provides white-labeled data infrastructure, analysis tools and delivery portals for kit, instrument, and solution providers. Today, LatchBio released a 25 million cell spatial atlas spanning ...